miR-199a-3p enhances cisplatin sensitivity of ovarian cancer cells by targeting ITGB8

Drug resistance remains a large obstacle for the treatment of ovarian cancer. miRNAs have been reported to be involved in cisplatin (CDDP) resistance in ovarian cancer. The aim of the present study was to investigate the function and mechanism of miR-199a-3p in the CDDP resistance in ovarian cancer....

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncol Rep
Glavni autori: Cui, Yajie, Wu, Fengqin, Tian, Defu, Wang, Ting, Lu, Tianjie, Huang, Xiying, Zhang, Peilian, Qin, Li
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2018
Teme:
Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5868401/
https://ncbi.nlm.nih.gov/pubmed/29436681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2018.6259
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items